Global Packaging and Labeling CDMO Market is projected to grow at a CAGR of 9-10% by 2027


Growth in the global packaging and labeling market is driven by several factors  including increased demand from OEMs to comply with regulatory requirements, cost savings, technical know-how, risk mitigation, increased drug manufacturing, and the rising prevalence of chronic diseases, infectious diseases, and genetic disorders.

Contract Development and Manufacturing Organizations (CDMOs) that specialize in packaging provide a wide range of services, including product development, clinical and commercial API production, medication product manufacturing, primary and secondary packaging, labeling, sterilization, and distribution. They also provide producers specialized packaging solutions for some difficult or niche items.

Demand for Eco-Friendly Packaging and Labeling, as well as Compliance with Regulatory Requirements Factors Driving the Market

The packaging and labeling CDMO business is expanding quickly. CDMOs' packaging and labeling techniques have seen considerable alterations in recent years, reflecting the industry's multidimensional growth. Primarily, sustainability has emerged as a prominent element, with a concentration on ecologically friendly packaging and labeling solutions.

For example,

  • Jabil Inc. announced its acquisition of Ecologic Brands, Inc., a notable sustainable packaging manufacturer, in January 2021. This strategic decision significantly expands Jabil's line of sustainable packaging.

Furthermore, severe regulations in industries like as pharmaceuticals and healthcare have boosted the demand for serialization and track-and-trace systems. CDMOs are using sophisticated technologies such as QR codes, RFID, and others to assure regulatory compliance, increase supply chain transparency, and prevent fraud.  

Factors Influencing the Global Packaging and Labeling CDMO Market

Global packaging and labeling CDMO market is expected to develop at a healthy rate during the forecast period. Filling and packaging are critical components of the whole contract manufacturing process. The demand for specialized packaging has given rise to a new business known as contract manufacturing. Most businesses now outsource their packaging to organizations that specialize in medicine and device packaging.

The expanding elderly population, severe regulatory requirements of governing bodies, and enhanced packaging technologies are some of the drivers that will drive the global packaging and labeling CDMO market. Furthermore, a lack of in-house packaging skills, knowledge, and financial restrictions

For instance,

  • In June 2023, Catalent announced that its OneBio® Suite, an integrated solution encompassing development, manufacturing, and supply, has been expanded to encompass various biologic modalities. This suite provides customers with an all-inclusive service designed to expedite the progression of programs from development to manufacturing. This includes activities such as fill/finish, packaging, and assistance with clinical supply and commercial launch. 

North America controls the majority of the global packaging and labeling CDMO market

In the future years, North America is likely to continue to dominate the worldwide market. This is mostly due to the region's growing older population, intensive R&D, and the presence of significant businesses. The Asia-Pacific area, on the other hand, is predicted to have the greatest CAGR throughout the projection period. The Asia-Pacific market is being driven by factors such as technical developments in the packaging industry and increased investments in the healthcare sector.

Competitive Landscape Analysis of the Global Packaging and Labeling CDMO Market

Aphena Pharma Solutions, Eurofins Scientific, Catalent, PCI Pharma, Pfizer CentreOne, Becton, Dickinson & Co, Almac Group, Jabil, Tecomet, and Integer are among the leading competitors in the industry.

Organic and inorganic growth strategies used by firms to get a market foothold

Players operating in this market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. For instance,

  • Almac Pharma Services launched its innovative Ultra-Low Temperature Solutions of commercial packaging, labeling, and distribution services in March 2022 to help with the introduction of Advanced Therapy Medicinal Products (ATMPs) from its European Centre of Excellence. Almac customized services for Just-in-Time labeling, packaging, and serialization at ultra-low temperatures (ranging from -20°C to -80°C) will provide clients with a uniquely tailored experience, ensuring that every aspect of this intricately detailed process is finely adjusted to meet the precise needs of both the client and their valuable product.

The packaging and labeling CDMO market is expanding and expected to gain traction in the coming years as a result of a strong emphasis on developing new drugs and devices, investment in R&D to introduce several advanced products, and aggressive organic and inorganic growth strategies adopted by the players


Get Detailed Insights on Packaging and Labeling CDMO Market with a Sample Report Copy/PDF @ https://meditechinsights.com/packaging-and-labeling-cdmo-market/

Comments

Post a Comment

Popular posts from this blog

The Transplantation Market Anticipated to Expand with 9-10% CAGR by 2029 as Need for Organ Transplants Rises

Image
  The market is propelled by various factors, including advancements in medical technology, the rising prevalence of chronic diseases that lead to organ failure, increasing awareness of transplantation as a viable treatment option, and evolving regulatory and reimbursement policies. In medical terms, transplantation refers to the surgical procedure of transferring cells, tissues, or organs from a donor to a recipient to replace malfunctioning or damaged body parts. Its primary goal is to restore normal function or improve the quality of life for the recipient. Transplantation is often used to treat end-stage organ failure, severe injuries, certain cancers, and congenital defects that are not manageable through other medical treatments. This specialized field requires careful matching of donors and recipients, advanced surgical techniques, and comprehensive post-transplant care to ensure success. Types of transplantation include: Kidney Transplantation: Involves replacing a fail...
Read more

Global 3D Cell Culture Market Seeks Prosperous Horizon: Double-Digit Growth Expected by 2027

Image
  The need for organ transplants and tissue engineering combined with developments in scaffold-free technology, a rise in investments and research and development (R&D) funding for cell-based studies, growing efforts to develop potential alternatives to animal-based testing, and the rising incidence of chronic diseases are some of the major factors propelling the growth of the global 3D cell culture market. 3D cell culture   is an important approach in cell biology and tissue engineering because it includes cultivating and analyzing cells in a three-dimensional environment that mimics the circumstances present in the human body. It has several advantages, such as the capacity to recreate in vivo settings, allow the creation of complex multicellular structures, and give realistic drug testing situations. Scaffold-based technologies employing materials such as hydrogels are employed for 3D cell culturing. Its uses include cancer research, tissue engineering, and medication d...
Read more

Global Tricuspid Valve Repair Market Driven by Innovation: Set to Surge with a US$2.5 Billion Market by 2028

Image
  Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcatheter tricuspid valve repair (TTVR), increased clinical research and trials activities for developing new tricuspid valve repair technologies, and rising incidence of tricuspid valve disorders are some of the key factors driving the global tricuspid valve repair market. • Medical technology advancements in the field of cardiac interventions. • Improved awareness of heart valve disorders. One of the four valves in our heart that regulates blood flow is the tricuspid valve . It is located between the ventricle and the atrium, the upper and lower chambers of our heart, on the right side. It guarantees that blood travels from the right atrium to the right ventricle in the proper path. As blood passes through the tricuspid valve, its three leaflets, or flaps, open and close. Tricuspid valve illnesses are disorders that some people have that impair the tricuspid valve's a...
Read more